Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mayumi Nakagawa

Concepts (235)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
171
4.370
 Why?
Human papillomavirus 16
11
2021
44
3.440
 Why?
Uterine Cervical Neoplasms
10
2024
299
3.190
 Why?
Papillomavirus Vaccines
7
2021
69
3.130
 Why?
Oncogene Proteins, Viral
11
2011
54
2.340
 Why?
Papillomaviridae
7
2019
104
2.220
 Why?
Repressor Proteins
9
2011
150
2.020
 Why?
Epitopes, T-Lymphocyte
7
2018
25
1.810
 Why?
Cancer Vaccines
3
2021
78
1.530
 Why?
T-Lymphocytes
6
2021
316
1.380
 Why?
Candida
4
2018
63
1.280
 Why?
CD8-Positive T-Lymphocytes
6
2018
128
1.250
 Why?
Cervix Uteri
3
2021
49
0.840
 Why?
Uterine Cervical Dysplasia
2
2015
51
0.790
 Why?
Immunity, Cellular
4
2013
62
0.700
 Why?
Lymphocytes, Tumor-Infiltrating
1
2021
78
0.690
 Why?
Epitopes
2
2015
62
0.670
 Why?
Langerhans Cells
3
2018
11
0.670
 Why?
Neoplasms
2
2021
1288
0.650
 Why?
Viral Load
2
2019
80
0.630
 Why?
Health Education
1
2021
156
0.620
 Why?
Cell Cycle Checkpoints
1
2019
32
0.610
 Why?
HLA Antigens
4
2006
53
0.590
 Why?
Humans
43
2025
52114
0.560
 Why?
Adult
21
2025
14095
0.550
 Why?
CD4-Positive T-Lymphocytes
3
2018
163
0.540
 Why?
Colorectal Neoplasms
1
2021
292
0.540
 Why?
Female
29
2025
28055
0.530
 Why?
Health Knowledge, Attitudes, Practice
1
2021
503
0.510
 Why?
Plasma Exchange
2
2014
25
0.490
 Why?
Cross Protection
1
2015
4
0.470
 Why?
T-Lymphocytes, Regulatory
2
2016
83
0.470
 Why?
Colposcopy
1
2015
17
0.450
 Why?
Interleukin-12
2
2018
26
0.450
 Why?
Adjuvants, Immunologic
2
2018
52
0.440
 Why?
Immunity, Innate
1
2015
112
0.430
 Why?
Interferon-gamma
2
2012
172
0.420
 Why?
Health
1
2013
21
0.420
 Why?
Lectins, C-Type
1
2013
30
0.420
 Why?
Middle Aged
15
2025
13028
0.420
 Why?
Papillomavirus E7 Proteins
8
2018
32
0.420
 Why?
Young Adult
9
2021
4307
0.410
 Why?
Patient Selection
1
2015
265
0.400
 Why?
Afibrinogenemia
1
2012
5
0.390
 Why?
Enzyme-Linked Immunospot Assay
1
2012
3
0.380
 Why?
T-Lymphocytes, Cytotoxic
4
2009
65
0.380
 Why?
Breast Neoplasms
1
2021
1199
0.380
 Why?
Cell Proliferation
5
2021
1017
0.350
 Why?
Vaginal Smears
3
2021
28
0.350
 Why?
Warts
1
2010
13
0.340
 Why?
Plateletpheresis
1
2010
7
0.340
 Why?
Early Detection of Cancer
3
2021
183
0.340
 Why?
Antigens, Fungal
1
2010
20
0.340
 Why?
Blood Preservation
1
2010
27
0.340
 Why?
Dermatitis
1
2010
36
0.330
 Why?
Blood Proteins
1
2010
84
0.330
 Why?
Anaphylaxis
1
2010
69
0.320
 Why?
Cells, Cultured
5
2021
1568
0.310
 Why?
Antigens, Viral
2
2009
43
0.290
 Why?
Immunotherapy
1
2010
240
0.290
 Why?
Telemedicine
1
2015
492
0.290
 Why?
Blood Platelets
1
2010
244
0.290
 Why?
Human papillomavirus 18
1
2008
9
0.290
 Why?
Host-Pathogen Interactions
2
2021
131
0.270
 Why?
Hematopoietic Stem Cell Transplantation
2
2025
597
0.270
 Why?
Dendritic Cells
1
2008
133
0.270
 Why?
Vaccinia virus
1
2007
6
0.270
 Why?
Immunoenzyme Techniques
1
2007
135
0.260
 Why?
Immunophenotyping
1
2007
117
0.260
 Why?
Neoplasm Staging
2
2025
766
0.250
 Why?
Aged
10
2025
10142
0.240
 Why?
Blood Component Removal
1
2025
17
0.230
 Why?
Cell Line, Tumor
5
2021
1418
0.230
 Why?
Isoantibodies
1
2004
28
0.220
 Why?
Neoplasm Grading
2
2021
125
0.220
 Why?
Lead
1
2004
33
0.220
 Why?
Infant, Very Low Birth Weight
1
2004
55
0.210
 Why?
Neutropenia
1
2004
113
0.210
 Why?
Endometrial Neoplasms
1
2025
143
0.210
 Why?
DNA, Viral
3
2011
138
0.210
 Why?
Oropharyngeal Neoplasms
1
2024
19
0.210
 Why?
Anus Neoplasms
1
2024
25
0.210
 Why?
Hematopoietic Stem Cells
1
2025
188
0.210
 Why?
Blood Transfusion
1
2004
129
0.200
 Why?
Coinfection
1
2024
41
0.200
 Why?
Penile Neoplasms
1
2024
45
0.200
 Why?
Adolescent
5
2021
6681
0.200
 Why?
High-Throughput Nucleotide Sequencing
2
2021
174
0.200
 Why?
Antibody Formation
1
2002
51
0.190
 Why?
Capsid Proteins
1
2002
24
0.190
 Why?
Practice Guidelines as Topic
1
2025
494
0.190
 Why?
Genes, T-Cell Receptor
1
2021
5
0.180
 Why?
Clone Cells
3
2007
76
0.180
 Why?
Treatment Outcome
3
2021
5456
0.180
 Why?
Cytokines
2
2016
621
0.180
 Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.180
 Why?
Pilot Projects
2
2021
712
0.180
 Why?
Mass Screening
2
2021
356
0.170
 Why?
Remission Induction
1
2021
218
0.170
 Why?
Lymphocyte Activation
1
2021
160
0.170
 Why?
Cystadenocarcinoma, Serous
1
2021
73
0.170
 Why?
Videotape Recording
1
2021
26
0.170
 Why?
Left-Right Determination Factors
1
2020
1
0.170
 Why?
Nodal Protein
1
2020
3
0.170
 Why?
Amino Acid Sequence
3
2008
566
0.170
 Why?
Mammography
1
2021
97
0.170
 Why?
Focus Groups
1
2021
195
0.160
 Why?
Multiple Myeloma
2
2025
2999
0.160
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
234
0.160
 Why?
Male
10
2024
26652
0.160
 Why?
Metagenome
1
2019
40
0.160
 Why?
Dose-Response Relationship, Drug
2
2016
1368
0.150
 Why?
Glioblastoma
1
2020
96
0.150
 Why?
Feasibility Studies
1
2021
399
0.150
 Why?
Parenteral Nutrition
1
2019
28
0.150
 Why?
Up-Regulation
1
2020
459
0.150
 Why?
Health Behavior
1
2021
256
0.150
 Why?
Transplantation Conditioning
1
2019
92
0.140
 Why?
DNA
1
2021
543
0.140
 Why?
Time Factors
2
2021
2970
0.140
 Why?
Bacteria
1
2019
220
0.140
 Why?
Leukocytes, Mononuclear
2
2016
122
0.140
 Why?
HLA-B Antigens
2
2008
8
0.140
 Why?
Age Factors
1
2021
1125
0.130
 Why?
Cell Line
2
2012
1018
0.130
 Why?
Ovarian Neoplasms
1
2021
458
0.130
 Why?
Brain Neoplasms
1
2020
287
0.130
 Why?
Histocompatibility Antigens Class II
2
2008
34
0.130
 Why?
Retrospective Studies
5
2025
6610
0.130
 Why?
Vaccines, Subunit
1
2016
15
0.120
 Why?
Head and Neck Neoplasms
1
2019
285
0.120
 Why?
Body Mass Index
1
2019
699
0.120
 Why?
Molecular Sequence Data
2
2008
766
0.120
 Why?
Adaptive Immunity
1
2015
32
0.120
 Why?
Chromatography, Liquid
1
2016
239
0.110
 Why?
Leukocyte Count
2
2004
72
0.110
 Why?
Peptides
2
2006
234
0.110
 Why?
Tandem Mass Spectrometry
1
2016
249
0.110
 Why?
Factor VIII
1
2014
23
0.110
 Why?
ADAM Proteins
1
2014
21
0.110
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
15
0.110
 Why?
Proteome
1
2016
169
0.110
 Why?
Antigens, CD1
1
2013
9
0.110
 Why?
Mannose-Binding Lectins
1
2013
7
0.110
 Why?
Receptors, Pattern Recognition
1
2013
4
0.110
 Why?
Indicators and Reagents
1
2013
36
0.110
 Why?
Intracellular Space
1
2013
24
0.110
 Why?
Skin Tests
1
2013
58
0.100
 Why?
Vaccination
1
2016
296
0.100
 Why?
Cadherins
1
2013
62
0.100
 Why?
Proteomics
1
2016
325
0.100
 Why?
Communication
1
2015
254
0.100
 Why?
Rural Health Services
1
2015
169
0.100
 Why?
Antigens, CD
1
2013
215
0.100
 Why?
Research Design
1
2015
367
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
580
0.100
 Why?
Socioeconomic Factors
1
2015
603
0.090
 Why?
Longitudinal Studies
2
2005
742
0.090
 Why?
Injections, Intralesional
1
2010
32
0.090
 Why?
Isotonic Solutions
1
2010
20
0.080
 Why?
Platelet Transfusion
1
2010
33
0.080
 Why?
P-Selectin
1
2010
27
0.080
 Why?
Sodium Chloride
1
2010
56
0.080
 Why?
Platelet Aggregation
1
2010
77
0.080
 Why?
Platelet Activation
1
2010
46
0.080
 Why?
Hypersensitivity
1
2010
81
0.080
 Why?
Japan
2
2025
38
0.080
 Why?
Complement Factor I
1
2008
2
0.070
 Why?
Polymerase Chain Reaction
1
2010
460
0.070
 Why?
HLA-A Antigens
1
2008
11
0.070
 Why?
Haplotypes
1
2008
95
0.070
 Why?
Antigen Presentation
1
2008
26
0.070
 Why?
Immunologic Memory
1
2008
32
0.070
 Why?
Prognosis
2
2025
2093
0.070
 Why?
Histocompatibility Antigens Class I
1
2008
47
0.070
 Why?
Signal Transduction
2
2020
1699
0.070
 Why?
Animals
2
2019
13332
0.070
 Why?
DNA, Recombinant
1
2007
15
0.070
 Why?
Genes, MHC Class I
1
2006
11
0.070
 Why?
Arkansas
1
2013
2016
0.060
 Why?
Binding, Competitive
1
2006
90
0.060
 Why?
Polymorphism, Single Nucleotide
1
2008
504
0.060
 Why?
Leukapheresis
1
2025
19
0.060
 Why?
Antigens, CD34
1
2025
73
0.060
 Why?
Calgranulin B
1
2005
4
0.060
 Why?
Calgranulin A
1
2005
5
0.060
 Why?
Cryopreservation
1
2025
40
0.060
 Why?
Epitope Mapping
1
2004
6
0.060
 Why?
Immunomagnetic Separation
1
2004
8
0.060
 Why?
Societies, Medical
1
2025
200
0.050
 Why?
Risk Factors
1
2013
3922
0.050
 Why?
Transplantation, Autologous
1
2025
480
0.050
 Why?
Phosphorylation
2
2020
523
0.050
 Why?
Sensitivity and Specificity
1
2005
871
0.050
 Why?
Mutation
1
2008
1318
0.050
 Why?
Tumor Virus Infections
1
2002
48
0.050
 Why?
Antibodies, Viral
1
2002
110
0.050
 Why?
Lactobacillus
1
2021
4
0.050
 Why?
Immunoglobulin G
1
2002
195
0.040
 Why?
SOX Transcription Factors
1
2021
4
0.040
 Why?
Cytodiagnosis
1
2021
42
0.040
 Why?
Neuroendocrine Cells
1
2021
9
0.040
 Why?
Biological Specimen Banks
1
2021
22
0.040
 Why?
Neoplasm Recurrence, Local
1
2025
630
0.040
 Why?
Cytoplasm
1
2021
93
0.040
 Why?
Cobalt
1
2020
17
0.040
 Why?
Neoplastic Stem Cells
1
2021
90
0.040
 Why?
Recurrence
1
2002
680
0.040
 Why?
Cell Hypoxia
1
2020
83
0.040
 Why?
Vulnerable Populations
1
2020
50
0.040
 Why?
Cohort Studies
1
2004
1541
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
57
0.040
 Why?
Community Health Workers
1
2020
49
0.040
 Why?
Cell Movement
1
2021
273
0.040
 Why?
Multivariate Analysis
1
2021
600
0.040
 Why?
Parenteral Nutrition, Total
1
2019
28
0.040
 Why?
Cell Survival
1
2020
596
0.040
 Why?
Sequence Analysis, DNA
1
2019
219
0.040
 Why?
Cell Differentiation
1
2021
670
0.040
 Why?
Phenotype
1
2021
794
0.040
 Why?
Models, Biological
1
2021
731
0.040
 Why?
Linear Models
1
2019
290
0.040
 Why?
Immunity, Humoral
1
2018
23
0.030
 Why?
Aged, 80 and over
1
2025
3382
0.030
 Why?
Infant, Newborn
1
2004
2859
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2020
853
0.030
 Why?
Autoantibodies
1
2014
120
0.030
 Why?
Mice, Inbred C57BL
1
2018
1872
0.020
 Why?
Immunosuppressive Agents
1
2014
249
0.020
 Why?
Combined Modality Therapy
1
2014
634
0.020
 Why?
Genetics, Population
1
2008
13
0.020
 Why?
Alleles
1
2008
277
0.020
 Why?
Mice
1
2018
5877
0.020
 Why?
Casein Kinase II
1
2005
9
0.010
 Why?
Cell Division
1
2005
288
0.010
 Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (235) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department